Novo Holdings skruer op for investeringerne i life science

Efter en række succesfulde investeringer melder Novo Holdings om øget lyst til at skyde penge i life science-selskaber. "Life science-sektoren ligger i vores DNA," siger adm. direktør Kasim Kutay.
Kasim Kutay, adm. direktør i Novo Holdings. | Photo: Kenneth Koustrup Lysbjerg/Finans
Kasim Kutay, adm. direktør i Novo Holdings. | Photo: Kenneth Koustrup Lysbjerg/Finans
AF MIKKEL AABENHUS HEMMINGSEN

Novo Holdings skruer op for investeringerne i life science- industrien og vil i de kommende år også sin eksponering mod industrien.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading